127 related articles for article (PubMed ID: 12958017)
1. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease.
Harnish DC; Albert LM; Leathurby Y; Eckert AM; Ciarletta A; Kasaian M; Keith JC
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G118-25. PubMed ID: 12958017
[TBL] [Abstract][Full Text] [Related]
2. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.
Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M
Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392
[TBL] [Abstract][Full Text] [Related]
3. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.
Peterson RL; Wang L; Albert L; Keith JC; Dorner AJ
Lab Invest; 1998 Dec; 78(12):1503-12. PubMed ID: 9881950
[TBL] [Abstract][Full Text] [Related]
4. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats.
Venkova K; Keith JC; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2004 Jan; 308(1):206-13. PubMed ID: 14569059
[TBL] [Abstract][Full Text] [Related]
5. Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
Chadwick CC; Chippari S; Matelan E; Borges-Marcucci L; Eckert AM; Keith JC; Albert LM; Leathurby Y; Harris HA; Bhat RA; Ashwell M; Trybulski E; Winneker RC; Adelman SJ; Steffan RJ; Harnish DC
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2543-8. PubMed ID: 15699342
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation.
Greenwood-Van Meerveld B; Venkova K; Keith JC
J Pharmacol Exp Ther; 2001 Oct; 299(1):58-66. PubMed ID: 11561063
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an estrogen receptor-beta agonist in animal models of human disease.
Harris HA; Albert LM; Leathurby Y; Malamas MS; Mewshaw RE; Miller CP; Kharode YP; Marzolf J; Komm BS; Winneker RC; Frail DE; Henderson RA; Zhu Y; Keith JC
Endocrinology; 2003 Oct; 144(10):4241-9. PubMed ID: 14500559
[TBL] [Abstract][Full Text] [Related]
8. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.
Breban M; Fernández-Sueiro JL; Richardson JA; Hadavand RR; Maika SD; Hammer RE; Taurog JD
J Immunol; 1996 Jan; 156(2):794-803. PubMed ID: 8543835
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease.
Peterson RL; Wang L; Albert L; Marchese E; Erickson J; Wong A; Mounts WM; Hayes L; Bouchard P; Keith J; Dorner AJ
Pharmacogenomics J; 2002; 2(6):383-99. PubMed ID: 12629504
[TBL] [Abstract][Full Text] [Related]
10. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.
Schultz M; Munro K; Tannock GW; Melchner I; Göttl C; Schwietz H; Schölmerich J; Rath HC
Clin Diagn Lab Immunol; 2004 May; 11(3):581-7. PubMed ID: 15138186
[TBL] [Abstract][Full Text] [Related]
11. Increased tissue protein synthesis during spontaneous inflammatory bowel disease in HLA-B27 rats.
El Yousfi M; Breuillé D; Papet I; Blum S; André M; Mosoni L; Denis P; Buffière C; Obled C
Clin Sci (Lond); 2003 Oct; 105(4):437-46. PubMed ID: 12793856
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease.
Hammer RE; Richardson JA; Simmons WA; White AL; Breban M; Taurog JD
J Investig Med; 1995 Jun; 43(3):262-8. PubMed ID: 7614072
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model.
Bowen-Yacyshyn MB; Bennett CF; Nation N; Rayner D; Yacyshyn BR
J Pharmacol Exp Ther; 2002 Sep; 302(3):908-17. PubMed ID: 12183646
[TBL] [Abstract][Full Text] [Related]
15. Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven.
Rauner M; Thiele S; Fert I; Araujo LM; Layh-Schmitt G; Colbert RA; Hofbauer C; Bernhardt R; Bürki A; Schwiedrzik J; Zysset PK; Pietschmann P; Taurog JD; Breban M; Hofbauer LC
Bone; 2015 Jun; 75():183-91. PubMed ID: 25746795
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-β signaling modulates epithelial barrier function.
Looijer-van Langen M; Hotte N; Dieleman LA; Albert E; Mulder C; Madsen KL
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G621-6. PubMed ID: 21252046
[TBL] [Abstract][Full Text] [Related]
17. Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease.
Thatch KA; Mendelson KG; Haber MM; Schwartz MZ
J Surg Res; 2009 Oct; 156(2):245-9. PubMed ID: 19524260
[TBL] [Abstract][Full Text] [Related]
18. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
[TBL] [Abstract][Full Text] [Related]
20. Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats.
Kerr SW; Wolyniec WW; Filipovic Z; Nodop SG; Braza F; Winquist RJ; Noonan TC
J Pharmacol Exp Ther; 1999 Nov; 291(2):903-10. PubMed ID: 10525115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
